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A cost-effective particle agglutination assay to detect viral 
antibodies in dried blood spots — a simple solution to 
HIV and HCV screening
*J J JO URBERT, **J B DEW AR, ***J W EINBERG, **M DE BEER, ****J S:PARKER, **A D STEELE
Abstract
Objectives: To conduct a serological survey of human immunodeficiency virus (HIV) and hepatitis C virus 
(HCV) in Gabon and Ga-Rankuwa, South Africa. A secondary objective was to test a novel, simple, 
inexpensive agglutination assay for anti-HIV IgG and anti-HCV IgG from blood samples stored as spots dried 
onto filter paper.
Design: Blood from heel pricks was dried onto filter paper and stored. Blood was eluted from the spots and 
serum antibody was then assayed using a modified agglutination assay — blood was added to gelatin 
agglutination beads that had been sensitised with viral antigen. A positive result showed as an agglutination 
pattern while a negative result appeared as a tight bead.
Subject: This was a hospital-based study involving 271 neonates at Ga-Rankuwa Hospital, South Africa, and 
856 patients ranging in age from three months to over 50 years who attended clinics in Gabon.
Results: Seroprevalence to HIV was determined in Ga-Rankuwa to be just under 14% (13.8%). Antibodies 
to HCV were not detected. In Gabon, the prevalence to HIV was just .under 1% (0.82%) with a relatively high 
incidence of HCV, nearing"4% (3.79%).
Conclusion: The sensitivity Of the agglutination assay compared favourably to enzyme immune assay (EIA) 
: with respect to sensitivity, simplicity and cost. This assay may be useful in sero-epidefnilogical assays in 
developing countries.
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Introduction
During the 1980s epidemiological data available on HIV 
indicated a low HIV seroprevalence in South Africa 
compared to the rest of Africa.1 In support of this, a study 
indicated a negative HIV incidence among adult Venda 
men and women diagnosed with sexually transmitted 
diseases.2 This correlated, at the time, with a negative 
incidence of HIV in the Kwa-Zulu region of South Africa. ’ 
Other studies compared the incidence of HIV in Kwa-Zulu 
in 1985 and again in 1991. These authors’* reported an 
extremely low HIV statistical incidence (12/100 000) in 
1985, but by 1991 the incidence of HIV in Kwa-Zulu had 
increased almost 200-fold, to 2 200/100 000. Nine years
later, the situation was alarmingly different, with the South 
African Department of Health assessing that about 10% of 
the South African population was HIV positive.5
A rapid increase in HIV seroprevalence prompts the 
need for a simple, rapid and effective method of screening 
blood samples for epidemiological survey. A valid 
assessment of HIV seroprevalence is aidedby unlinked 
anonymous screening — informed consent and councelling 
is not necessary — making use of simple but accurate 
assays. Trends in HIV seroprevalence can be determined 
by repeat surveys/’
One such method for HIV seroprevalence testing makes 
use of a simple method for obtaining blood samples from 
heel pricks. The blood is spotted onto filter paper and
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stored as dried blood spots (DBS). An advantage of this is 
that the DBS can be simply stored or placed in an envelope 
prior to posting before being eluted to assay for HIV 
nucleic acids or antibodies.7 Blood that has been eluted 
from the DBS can be assayed by the polymerase chain 
reaction (PCR) or EIA to determine HIV seroprevalencc. 
Anonymous testing of DBS cluatcs with methods such as 
PCR and ELISA has been used to determine HIV prevalence 
in Asia,* in Canada,'' in Spain,11’ in Sierra Leone11 and in 
Zambia.17 This method has also been used to diagnose 
malaria in Singapore1-1 and Malaysia,14 trypanosomosis in 
Zambia,1-'’ cysticercosis in Bolivia"' and toxoplasmosis in 
Denmark and Massachusetts.17-ls
A simple agglutination assay, involving the addition of 
blood eluted from DBS to agglutination beads sensitised 
with HIV antigen, has been shown to be a sensitive and 
specific alternative to PCR and ELISA in assays to 
determine HIV seroprevalence. In this way, unlinked 
anonymous testingof DBS using this modified agglutination 
assay has been achieved in determining HIV seroprevalence 
in three Thames regions|g-2" and in Edinburgh, Scotland.21 
Agglutination beads sensitised with HCV antigens have 
also been used to test for HCV seroprevalence in Parkistan.22
This article describes the use of a simple, inexpensive 
agglutination assay to detect anti-HIV IgG and anti-HCV 
IgG in blood samples that are efficiently obtained and 
stored as spots dried onto filter paper.
Materials and Methods
Dried blood spots were obtained from 271 neonates 
attending Ga-Ranku'wa Hospital, Gauteng, South Africa 
and from 856 Gabonese patients from the age of three 
months to over 50 years.
The elution and testing of sera from DBS was performed 
as described.iy Blood samples were routinely taken by heel 
prick from newborn babies, or from finger pricks from 
adults, and spotted onto Whatman™ 3MM filter paper. A 
5,5mm punch of DBS was eluted in flat-bottomed 96 well 
master plates into 100 ml elution buffer (PBS) pH 7.2,
0.05% Tween 20, 0.05% sodium azide — PBS-Tw). The 
plates were shaken slowly for 30 minutes at room 
temperature and then stored overnight at 4°C. The next 
morning the plates were shaken fast for three minutes'. 
Note that only 11 of the 12 rows of the plate were used to 
test samples and the 12th row was used to titrate the 
positive control. The eluates from the DBS were diluted 
one in five in PBS-Tw and then 30 ml of each was 
transferred to each V-shaped well of a test microtitre plate. 
This means that each plate comprised 88testsera andeight 
dilutions of the positive control serum. The positive control 
consisted of. HIV posititve serum in freshly drawn HIV 
negative whole blood. This was spotted onto filter paper 
and allowed to dry at room temperature for 48 hours. A 
control DBS was eluted into the first well in a master plate 
and then a 100 ml serial doubling dilution of this was 
prepared usingPBS-Tw. The dilutions were then transferred 
to the test plate.
To the sera were added 25 ml of a 10 dilution of gelatine 
particles (Fujirebio™) sensitised with HIV-1 (or HCV) 
antigens. The plate was then covered, shaken at 260g for 
two minutes, left at room temperature for 15 minutes and 
then placed on a light box at an angle of 70°. The results 
were read after 10 minutes. A negative result showed as a 
tight bead while ft positive result showed as a discrete 
agglutination pattern. Reactive eluates were re-tested. If 
again reactive they titrated across the endpoint and then 
aspirated from the plate for storage at -20°C.
Results
The DBS samples were tested for anti-HIV IgG and anti- 
HCV IgG as described in the methods section. Within the 
Ga-Rankuwa neonates, seroprevalence to HIV was 
determined to be 36/271 = 14%. The seroprevalencc to 
anti-HCV IgG was similarly performed and was not 
detectable.
The DBS from Gabon were tested as to HIV and HCV 
seroprevalence using this modified agglutination assay. 
Overall, anti-HIV IgG was demonstrated in 7/856 (under 
1%) of the cohort while anti-HCV IgG was determined in 
25/856 (over 3% of the patients). The seven HIV positives 
were confirmed with enzyme immunoassay (EIA) as were 
the 25 samples that tested positive for HCV.
Discussion
The incidence of HIV in South Africa contrasts to HIV 
seroprevalence in the West African country of Gabon. 
Between 1986 and 1994, the seroprevalence to HIV in the 
general population in Gabon was reported as low and 1 
remained stable at just above 2%.23 A more recent report, 
published in 1998, confirmed this in the general population 
of Gabon.24 In contrast to those figures, use of DBS and the 
agglutination assay in the current study indicated a reduction 
•in the seropositivity to HIV in Gabon — with an overall 
incidence of less than 1%. These contradictory findings 
may be ascribed to the fact that the figures published in 
1996 and 1998 reflected the seroprevalence to HIV-1 
amongst the sexually active in the general Gabon 
population. The present study involved testing blood 
samples from the general population, including neonates, 
as well as individuals over the age of 50 years. Although 
relatively low, published figures cautioned as to a doubling 
in the seroprevalence to HIV-1 within eight years in 
Gabon.24
The current study indicates a low seroprevalence to 
HCV in South African neonates. This correlates with 
published data25-26 that reported an HCV prevalence of 
1.8% and 0.64% in black South Africans, respectively. 
While the seroprevalence to HCV as reported by Schoub ef , 
al.25 was low in males (at nearly 3%) this figure was 
significantly higher than the seroprevalence in females (at 
under 1%).
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In comparison to the HCV seroprevalence in South 
Africa, the current study shows a relatively high HCV 
seroprevalence in Gabon (at over 3% of the general 
population). This indicated that in Gabon, more than three 
times as many females are infected with HCV (over 4% of 
total) compared to males (over 1% total) tested. This 
contrasts with results obtained to 1991 where an ELISA 
was used to determine the prevalence rate of HCV in 
Gabon. In this study the HCV seroprevalence was 
determined in blood donors (mainly men) and pregnant 
women to be over 2% and under 1% respectively.21 While 
these figures indicate almost a doubling in the incidence of 
HCV in Gabon in the eight years to 1998, it shows almost 
a sixfold increase in the prevalence of HCV in Gabonese 
women in this time period.
In Lahore, Pakistan, another developing country, the 
above described agglutination assay of DBS-eluted blood 
was compared to EIA as well as a third generation RIBA 
test as to their detection of antibodies to HCV in DBS 
samples. These results indicate that 6,7% of 417 mothers 
and 1.3% of their 538 children were HCV seropositive.22 
These authors indicate that the use of the modified 
agglutination assay is comparable in sensitivity to the EIA 
and RIBA test but that the antigens used in the agglutination 
assay should be appropriate to the viral strain endemic in 
any particular country. Pakistan has a high incidence of 
HCV compared to other countries and this may be ascribed 
to increased risk of transmission due to therapeutic use of 
contaminated needles and the practice of transfusion with 
unscreened blood.
Conclusion
The DBS/agglutination method is very simple and cost- 
effective, at approximately 10% of the cost of a standard 
indirect ELISA test. Results using this technique have 
been confirmed by repeat testing of blood samples using 
EIA and RIBA. The RIBA test is an example of an 
expensive technique requiring well-trained staff and an 
appropriately appointed modern laboratory. Results using 
the DBS/agglutination assay can be obtained under much 
simpler conditions, reinforcing the suitability of such 
technology in developing countries and rural areas. As 
more vaccines are developed for use in developing countries, 
there is an ongoing need to develop sensitive assays that 
allow for rapid, appropriate testing of both antibodies and 
antigens. The assay described here is not a replacement for 
EIA or PCR diagnosis, but, as it combines low cost, 
simplicity, accuracy and'sensitivity, it is appropriate in 
determining sero-epidemiological trends.
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